--2024/Q4-- / 7.817M--
--2024/Q3-- / 22.583M--
Aug 6, 20242024/Q2356.000K / 8.260M--
May 9, 20242024/Q1481.000K / 6.361M--
--2023/Q42.042M / 8.105M--
US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 0.880
- -0.010-1.12%
Close Aug 16 16:00 ET
- 0.895
- +0.015+1.69%
Post 19:58 ET
183.23MMarket Cap-637P/E (TTM)
0.946High0.880Low4.99MVolume0.882Open0.890Pre Close4.54MTurnover2.91%Turnover RatioLossP/E (Static)208.22MShares1.48052wk High7.72P/B151.07MFloat Cap0.29152wk Low--Dividend TTM171.67MShs Float51.375Historical High--Div YieldTTM7.43%Amplitude0.291Historical Low0.908Avg Price1Lot Size
Sangamo Therapeutics Key Stats
Sangamo Therapeutics Q2 2024 Earnings Date
Currency：USDAug 6, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 8.26M | 356.00K | -7.90M |
| Miss Est. | +20.85% | -94.79% | -95.69% |
| EPS | -0.15 | -0.18 | -0.03 |
| Miss Est. | +77.85% | +72.73% | -23.12% |
Analyst Rating
Aug 7, 2024
Sangamo Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Sangamo Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
